Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shenqi Detoxification Granule (SDG) is a traditional Chinese herbal formula used for the treatment of chronic renal failure. It works by inhibiting progressive fibrosis, a key pathological process in chronic renal disease. Its mechanism involves reducing the expression of connective tissue growth factor (CTGF) and platelet-derived growth factor-B (PDGF-B), which play important roles in extracellular matrix abnormal accumulation. Additionally, it improves nitric oxide (NO) levels and reduces endothelin-1 (ET-1) levels, thereby improving endothelial function and mitigating their roles in mediating renal fibrosis. The formula comprises 12 Chinese herbs, including Radix Astragali (Huang Qi), Salvia miltiorrhiza (Dan Shen), and Angelica sinensis (Dang Gui).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shenqi Detoxification Granule.